Univariate analysis indicated that high FABP7 expression, PRS type, tumor grade, age, chemotherapy status, IDH mutation status, and 1p19q codeletion status were associated with reduced OS in patients with glioma (Figure 3(g)). The gene discussed is IDH1; the disease is central nervous system cancer.